Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsIndependent Health step therapy coverage update | …
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentIndependent HealthPolicy N/A

    Step therapy criteria and history-based prior authorization for formulary medications

    Customize your policy alerts

    Sign up for all Independent Health policy alerts

    Know when Independent Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines step therapy requirements for medications on Independent Health 2025 formularies and explains when prior authorization is required based on recent prescription history; affects prescribers, pharmacies, and members covered by Independent Health formularies in NC.

    Policy Summary
    PayerIndependent Health
    PolicyStep therapy criteria and history-based prior authorization for formulary medications
    Policy CodePolicy N/A
    Change TypeAnnual maintenance — no material changes
    Effective DateJan 1, 2025
    Last ReviewJan 1, 2025
    Next Review DateN/A
    Key ActionDocument the required prior or concurrent medication fill in the patient's Independent Health pharmacy profile to allow online processing without prior authorization.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    I–III, FEHB, Essentialformularies named
    20+distinct product entries
    90–365 dayscommon lookback windows
    NCapplicable state
    Prior authorizationPA trigger

    Product-specific Coverage Criteria

    Aczone (dapsone gel 7.5%) — initial coverage condition

    Covered without prior authorization when ALL of the following are met

    Aczone (dapsone gel 7.5%): Pharmacy profile documents a generic 5% dapsone fill within the previous 90 days90 days

    If not met, prior authorization required

    AIRSUPRA — initial coverage condition

    Covered without prior authorization when ALL of the following are met

    AIRSUPRA inhalation: Pharmacy profile documents an inhaled corticosteroid or combination fill within the previous 120 days120 days

    If not met, prior authorization required

    Policy Summary
    PayerIndependent Health
    PolicyStep therapy criteria and history-based prior authorization for formulary medications
    Policy CodePolicy N/A
    Change TypeAnnual maintenance — no material changes
    Effective DateJan 1, 2025
    Last ReviewJan 1, 2025
    Next Review DateN/A
    Key ActionDocument the required prior or concurrent medication fill in the patient's Independent Health pharmacy profile to allow online processing without prior authorization.
    SourceLink
    On This Page
    Product-specific Coverage CriteriaPrior Authorization & Documentation RequirementsAffected Products & Coding NotesInitial Therapy and Start-of-Care RulesStep Therapy MatrixPolicy BackgroundKey Definitions

    ALOCRIL — initial coverage condition

    Covered without prior authorization when ALL of the following are met

    ALOCRIL ophthalmic: Pharmacy profile documents a fill of Zaditor or Alaway OTC within the previous 90 days90 days

    If not met, prior authorization required

    GLP-1 antidiabetics — initial coverage condition

    Covered without prior authorization when ANY of the following are met

    GLP-1 antidiabetics: Pharmacy profile documents type 2 diabetes OR a trial of any oral antidiabetic (excluding metformin) within the past 130 days130 days

    If not met, prior authorization required

    Antiemetics — initial coverage condition

    Covered without prior authorization when ALL of the following are met

    Antiemetics (selected products): Pharmacy profile documents a generic ondansetron fill within the previous 180 days180 days

    If not met, prior authorization required

    Belsomra — initial coverage condition

    Covered without prior authorization when ALL of the following are met

    Belsomra: Pharmacy profile documents a generic zolpidem fill within the previous 365 days365 days

    If not met, prior authorization required

    Binosto — initial coverage condition

    Covered without prior authorization when ALL of the following are met

    Binosto: Pharmacy profile documents an alendronate fill within the previous 90 days90 days

    If not met, prior authorization required

    Bromfenac ophthalmic — initial coverage condition

    Covered without prior authorization when ALL of the following are met

    Bromfenac ophthalmic 0.07%: Pharmacy profile documents generic bromfenac ophthalmic solution 0.09% once daily fill within the previous 90 days90 days

    If not met, prior authorization required

    Fluorouracil topical — initial coverage condition

    Covered without prior authorization when ALL of the following are met

    Fluorouracil topical 0.5%: Pharmacy profile documents a fluorouracil topical fill within the previous 90 days90 days

    If not met, prior authorization required

    Entacapone / ONGENTYS — initial coverage condition

    Covered without prior authorization when ALL of the following are met

    Entacapone / ONGENTYS: Pharmacy profile documents concurrent use of a levodopa/carbidopa productconcurrent use

    If not met, prior authorization required

    Ongentys initial edit criteria

    Ongentys (entacapone / ONGENTYS): Covered through online processing when ALL of the following are met

    Ongentys online pass criteria: Patient's Independent Health prescription history documents concurrent use of a levodopa/carbidopa productconcurrent use documented

    If not met, prior authorization required

    Diclofenac (migraine) initial edit criteria

    Diclofenac potassium (migraine) packet: Covered through online processing when ALL of the following are met

    Diclofenac (migraine) online pass criteria: Independent Health prescription history documents a generic NSAID fill (eg, naproxen, ibuprofen, celecoxib) within the previous 180 daysfill in prior 180 days

    If not met, prior authorization required

    Eucrisa initial edit criteria

    Eucrisa ointment 2%: Covered through online processing when ALL of the following are met

    Eucrisa online pass criteria: Independent Health prescription history documents a fill for tacrolimus, pimecrolimus, or a topical corticosteroid within the previous 365 daysfill in prior 365 days

    If not met, prior authorization required

    Fetzima initial edit criteria

    Fetzima formulations: Covered through online processing when ALL of the following are met

    Fetzima online pass criteria: Independent Health prescription history documents venlafaxine extended-release capsule fill within the previous 90 daysfill in prior 90 days

    If not met, prior authorization required

    Glycopyrrolate initial edit criteria

    Glycopyrrolate oral solution: Covered through online processing when ALL of the following are met

    Glycopyrrolate online pass criteria: Independent Health prescription history documents a generic glycopyrrolate tablet fill within the previous 90 daysfill in prior 90 days

    If not met, prior authorization required

    Gabapentin-class initial edit criteria

    Gabapentin once-daily products: Covered through online processing when ALL of the following are met

    Gabapentin online pass criteria: Independent Health prescription history documents gabapentin fill within the previous 90 daysfill in prior 90 days

    If not met, prior authorization required

    Doxercalciferol initial edit criteria

    Doxercalciferol capsules: Covered through online processing when ALL of the following are met

    Doxercalciferol online pass criteria: Independent Health prescription history documents a calcitriol fill within the previous 90 daysfill in prior 90 days

    If not met, prior authorization required

    Horizant initial edit criteria

    Horizant ER products: Covered through online processing when ALL of the following are met

    Horizant online pass criteria: Independent Health prescription history documents gabapentin fill within the previous 90 daysfill in prior 90 days

    If not met, prior authorization required

    Amphetamine-dextroamphetamine initial edit criteria

    Amphetamine-dextroamphetamine ER products: Covered through online processing when ALL of the following are met

    AMPH-DEX online pass criteria: Independent Health prescription history documents an amphetamine-dextroamphetamine extended-release capsule fill within the previous 90 daysfill in prior 90 days

    If not met, prior authorization required

    Memanne/Namzaric initial edit criteria

    Memanne / Namzaric ER combination products: Covered through online processing when ALL of the following are met

    Memanne/Namzaric online pass criteria: Independent Health prescription history documents donepezil or memantine fill within the previous 90 daysfill in prior 90 days

    If not met, prior authorization required

    Step therapy / Prior authorization per product

    Covered with step therapy / prior authorization based on documented prior or concurrent pharmacy fills

    product-specific routing: For each listed product, online routing is permitted if the patient's Independent Health pharmacy profile documents the specified prior or concurrent medication fill within the defined lookback window; otherwise prior authorization is required.see child nodes

    Lookback windows vary by product

    Serevent Diskus

    Serevent Diskus (50 mcg) coverage routing

    Serevent Diskus routing: Prescription routes online if Independent Health prescription history documents concurrent use of an inhaled corticosteroid or Spirivaconcurrent use documented

    If not documented, prior authorization is required.

    FABIOR / Tazarotene

    FABIOR and tazarotene topical products coverage routing

    FABIOR/tazarotene routing: Prescription routes online if prescription history documents that tretinoin or adapalene was filled within the previous 90 daystretinoin/adapalene fill within 90 days

    If not documented, prior authorization is required.

    Tramadol ER

    Tramadol ER products coverage routing

    Tramadol ER routing: Prescription routes online if prescription history documents that immediate-release tramadol was filled within the previous 90 daysIR tramadol fill within 90 days

    If not documented, prior authorization is required.

    Trintellix

    Trintellix (vortioxetine) coverage routing

    Trintellix routing: Prescription routes online if prescription history documents that a generic SSRI (e.g., sertraline, fluoxetine, escitalopram) was filled within the previous 90 daysgeneric SSRI fill within 90 days

    If not documented, prior authorization is required.

    Febuxostat (Uloric)

    Febuxostat (Uloric) coverage routing

    Febuxostat routing: Prescription routes online if prescription history documents that allopurinol was filled within the previous 90 daysallopurinol fill within 90 days

    If not documented, prior authorization is required.

    XPHOZAH (tenapanor)

    XPHOZAH (tenapanor) coverage routing

    XPHOZAH routing: Prescription routes online if prescription history documents concurrent (within the previous 120 days) use of a phosphate binderphosphate binder use within 120 days

    If not documented, prescriber must request authorization via standard process.

    Sublingual zolpidem

    Sublingual zolpidem coverage routing

    Sublingual zolpidem routing: Prescription routes online if prescription history documents that generic zolpidem was filled within the previous 90 daysgeneric zolpidem fill within 90 days

    If not documented, prior authorization is required.

    Prior Authorization & Documentation Requirements

    Step Therapy

    General step-therapy rule

    Prior authorization is required when the member's pharmacy history does not meet the step/history criteria listed below. For history-based edits, the pharmacy profile must document the specified prior fill(s) or concurrent therapy within the stated timeframe; otherwise submit a prior authorization with clinical justification.

    • General rule: Attempted step(s) or required concurrent therapy must be documented in the member's Independent Health pharmacy history within the timeframe noted for each product or a prior authorization will be required.
    • When pharmacy-history criteria are met the claim will process online; when not met the pharmacy will obtain prior authorization.
    • Prescribers may request authorization via standard prior authorization channels and should include documentation of prior therapy, reason for failure/intolerance, or clinical rationale for bypassing step therapy.
    Prior Authorization

    Ongentys PA requirement

    Ongentys (opicapone) requires prior authorization when the member's pharmacy profile does not document concurrent use of a levodopa/carbidopa product. Additionally, some Ongentys edits check for prior entacapone or levodopa/carbidopa-entacapone use — ensure relevant concurrent or recent therapy is documented.

    • Products affected: ONGENTYS CAPSULE 50 MG ORAL
    • Required history: Concurrent use of a levodopa/carbidopa product (documented in pharmacy history).
    • Related check: Entacapone/levodopa-carbidopa-entacapone history in past 180 days may be used for routing.
    Prior Authorization

    Eucrisa PA requirement

    Eucrisa requires prior authorization when the pharmacy profile does not document a recent topical calcineurin inhibitor or topical corticosteroid (tacrolimus, pimecrolimus, or topical corticosteroid) fill within the previous 365 days.

    • Products affected: topical crisaborole products (Eucrisa).
    • Required history: Fill for tacrolimus, pimecrolimus, or a topical corticosteroid within the previous 365 days.
    Prior Authorization

    Fetzima PA requirement

    Fetzima (levomilnacipran) requires prior authorization when the patient's pharmacy history does not document a recent venlafaxine extended-release fill within the previous 90 days.

    • Products affected: FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR (various strengths).
    • Required history: Venlafaxine ER fill within previous 90 days or submit PA with clinical rationale.
    Prior Authorization

    Gabapentin-class PA requirement

    Gabapentin-class products (and specific branded gabapentin formulations) require prior authorization when the pharmacy profile does not document a gabapentin fill within the previous 90 days.

    • Products affected: branded and extended-release gabapentin products (e.g., once-daily gabapentin 600 mg, HORIZANT).
    • Required history: Gabapentin fill within previous 90 days.
    Prior Authorization

    Doxercalciferol PA requirement

    Doxercalciferol and other vitamin D analogs require prior authorization when the pharmacy profile does not document a calcitriol fill within the previous 90 days.

    • Products affected: doxercalciferol capsule 2.5 mcg and similar agents.
    • Required history: Calcitriol fill within previous 90 days.
    Prior Authorization

    Horizant PA requirement

    Horizant (gabapentin enacarbil) requires prior authorization when the pharmacy profile does not document a gabapentin fill within the previous 90 days.

    • Products affected: HORIZANT TABLET EXTENDED RELEASE 600 MG ORAL
    • Required history: Gabapentin fill within previous 90 days.
    Prior Authorization

    Memanne/Namzaric PA requirement

    Memantine/donepezil combination products (Namzaric / memanne + donepezil formulations) require prior authorization when the pharmacy profile does not document a recent donepezil or memantine fill within the previous 90 days.

    • Products affected: MEMANNE HCL-DONEPEZIL HCL ER CAPSULE, NAMZARIC CAPSULE EXTENDED RELEASE.
    • Required history: Donepezil or memantine fill within previous 90 days; documentation of prior fills should be included with PA requests.
    Prior Authorization

    Trintellix: PA when no recent SSRI

    Trintellix requires prior authorization when the patient's pharmacy history does not document use of a generic SSRI within the previous 90 days.

    • Products affected: TRINTELLIX TABLET 5 MG ORAL (and other strengths).
    • Required history: Fill for a generic SSRI (e.g., sertraline, fluoxetine, escitalopram) within previous 90 days.
    Prior Authorization

    Febuxostat: PA when no recent allopurinol

    Febuxostat (Uloric) requires prior authorization when the patient's pharmacy history does not document an allopurinol fill within the previous 90 days.

    • Products affected: FEBUXOSTAT TABLET 40 MG ORAL, 80 MG ORAL.
    • Required history: Allopurinol fill within previous 90 days.
    Prior Authorization

    XPHOZAH: PA when no recent phosphate binder

    Xphozah (tenapanor) requires prior authorization when the pharmacy profile does not document concurrent use of a phosphate binder within the previous 120 days. If the pharmacy history does not show a phosphate binder, the prescriber may submit a prior authorization with clinical justification for review.

    • Products affected: XPHOZAH TABLET 30 MG ORAL
    • Required history: Concurrent use of a phosphate binder within previous 120 days; prescriber can request authorization if history is not documented.
    Prior Authorization

    AMPH-DEX prior fill check

    Amphetamine-dextroamphetamine extended-release products require prior authorization when the member's pharmacy history does not document prior fills for amphetamine-dextroamphetamine ER within the previous 90 days.

    • Products affected: AMPH-DEX ER capsules (multiple strengths).
    • Required history: Amphetamine-dextroamphetamine ER fill within previous 90 days.
    Prior Authorization

    Entacapone / ONGENTYS

    Entacapone / levodopa-carbidopa-entacapone history is checked for certain Parkinson's disease adjunct therapies. Prior authorization is required when the pharmacy profile does not document concurrent or recent use as specified in the product-specific criteria.

    • Products affected: ONGENTYS and related adjunctive Parkinson's agents.
    • Required history: Concurrent entacapone or levodopa-carbidopa-entacapone use within product-specified timeframe (often past 180 days).
    Step Therapy

    Xphozah step rule

    Xphozah step rule: authorization routing is based on documented concurrent phosphate binder use within 120 days. If not documented, the claim will require prior authorization and the prescriber must supply clinical justification for use without a documented binder.

    • Step rule: Concurrent phosphate binder documented = claim routes online; no documented binder = PA required.
    • Operational note: Prescribers may request authorization and should include prior therapy or rationale.

    Affected Products & Coding Notes

    Products Affectedmixed
    SEREVENT DISKUS AEROSOL POWDER BREATH ACTIVATED 50 MCG/ACT INHALATIONProduct listed in policy excerpt
    Products Affectedmixed
    No codes listed
    Products Affectedmixed
    FABIOR FOAM 0.1 % EXTERNALProduct listed in policy excerpt
    tazarotene cream 0.05 % externalProduct listed in policy excerpt
    tazarotene cream 0.1 % externalProduct listed in policy excerpt
    tazarotene gel 0.05 % externalProduct listed in policy excerpt
    tazarotene gel 0.1 % externalProduct listed in policy excerpt
    Products Affectedmixed
    tramadol hcl (er biphasic) tablet extended release 24 hour 100 mg oralProduct listed in policy excerpt
    tramadol hcl (er biphasic) tablet extended release 24 hour 200 mg oralProduct listed in policy excerpt
    tramadol hcl (er biphasic) tablet extended release 24 hour 300 mg oralProduct listed in policy excerpt
    Products Affectedmixed
    TRINTELLIX TABLET 10 MG ORALProduct listed in policy excerpt
    TRINTELLIX TABLET 20 MG ORALProduct listed in policy excerpt
    TRINTELLIX TABLET 5 MG ORALProduct listed in policy excerpt
    Products Affectedmixed
    febuxostat tablet 40 mg oralUloric product listed
    febuxostat tablet 80 mg oralUloric product listed
    Products Affectedmixed
    XPHOZAH TABLET 20 MG ORALProduct listed in policy excerpt
    XPHOZAH TABLET 30 MG ORALProduct listed in policy excerpt
    Products Affectedmixed
    zolpidem tartrate tablet sublingual 1.75 mg sublingualProduct listed in policy excerpt
    zolpidem tartrate tablet sublingual 3.5 mg sublingualProduct listed in policy excerpt
    Prior-fill lookback windows
    Examples of lookback windows90 days; 120 days; 130 days; 180 days; 365 days
    Source guidanceUsed as product-specific prior-fill windows to permit online routing without prior authorization
    Applies toMultiple formulary products with 'ST' designation
    NSAID prior fill window
    NSAID prior fill window180 days
    Typical triggerGeneric NSAID (eg, naproxen, ibuprofen, celecoxib) fill documented in prior 180 days to avoid PA for diclofenac (migraine)
    If not metPrior authorization required and claim routed for review
    Topical therapy prior fill window
    Topical therapy prior fill window365 days
    ExamplesTacrolimus, pimecrolimus, or topical corticosteroid fill within previous 365 days to avoid PA for Eucrisa
    If not metPrior authorization required
    Typical prior fill window
    Typical prior fill window90 days
    Common usesUsed for products such as Fetzima (venlafaxine XR), gabapentin-class, doxercalciferol, Horizant, amphetamine-dextroamphetamine ER, memantine/donepezil combinations
    ImplicationIf no qualifying fill in prior 90 days, prior authorization is required
    pharmacy lookback windows
    Pharmacy lookback windows (range)30 days, 90 days, 120 days, 180 days depending on product
    Short lookback examples30 days for oral antifungal (Oravig) documentation
    Longer lookback examples120–180 days for products requiring concurrent therapy (eg, inhaled corticosteroid within 120 days for AIRSUPRA; entacapone/levodopa within 180 days for ONGENTYS)
    lookback fill window
    Default lookback fill window90 days
    Products using this windowTramadol ER (IR tramadol), Trintellix (generic SSRI), Febuxostat (allopurinol), sublingual zolpidem (generic zolpidem)
    Consequence if absentPrior authorization required when no qualifying fill in prior 90 days
    XPHOZAH phosphate binder lookback
    XPHOZAH phosphate binder lookback120 days
    RequirementConcurrent use of a phosphate binder documented within the previous 120 days to route XPHOZAH online
    If not metPrescriber must request authorization via standard process

    Initial Therapy and Start-of-Care Rules

    inv-133: GLP-1 antidiabetics initial therapy

    Initial use conditions for GLP-1 antidiabetics

    GLP-1 initial criteria: Patient has type 2 diabetes OR has tried any oral antidiabetic drug (excluding metformin) within the past 130 days130 days

    If not met, prior authorization required

    inv-134: Initial therapy pharmacy-history requirements

    Initial dispensing allowed without prior authorization only when the required prior fill(s) are present in Independent Health prescription history within the stated look-back periods; otherwise prior authorization is required.

    Product-specific initial prior-fill requirement: See per-product criteria in coverage.criteria_setssee per-product thresholds

    If not met, prior authorization required

    inv-135: High-potency narcotics initial therapy

    High-potency opioid initiation

    opioid initiation safety: Online dispensing is allowed only if the patient's pharmacy history documents narcotic fills within prior 120 days; otherwise prior authorization required to prevent initiation in opioid-naïve patients.120 days

    applies to listed high-potency narcotics

    inv-136: Memantine/donepezil prior therapy

    Memantine/donepezil combination products

    donepezil/memantine prior use: Online dispensing allowed if donepezil or memantine was filled within previous 90 days; otherwise prior authorization required.90 days

    applies to memanne/donepezil ER products and Namzaric listing

    inv-137: Ongentys prior/concurrent therapy

    Ongentys (opicapone) co-therapy requirement

    entacapone/levodopa-carbidopa-entacapone history: Online dispensing allowed if pharmacy history documents entacapone or levodopa-carbidopa-entacapone product fill in past 180 days; otherwise prior authorization required.180 days

    applies to ONGENTYS 25 mg and 50 mg

    inv-138: Tramadol ER initial therapy

    Tramadol ER initial step requirement

    Tramadol ER initial: Require prior IR tramadol fill within 90 days to avoid PAIR tramadol within 90 days

    If not met, PA required.

    inv-139: Trintellix initial therapy

    Trintellix initial step requirement

    Trintellix initial: Require generic SSRI fill within 90 days to avoid PAgeneric SSRI within 90 days

    If not met, PA required.

    Step Therapy Matrix

    MedicationBypass requirementLookback / threshold
    Aczone (dapsone gel 7.5%)
    Pharmacy profile documents a generic 5% dapsone fill to bypass prior authorization
    90 days
    MedicationBypass requirementLookback / threshold
    AIRSUPRA (inhalation)
    Pharmacy profile documents an inhaled corticosteroid or combination fill to bypass prior authorization
    120 days
    MedicationBypass requirementLookback / threshold
    ALOCRIL (ophthalmic)
    Pharmacy profile documents a Zaditor or Alaway OTC fill to bypass prior authorization
    90 days
    MedicationBypass requirementLookback / threshold
    GLP-1 antidiabetics
    Pharmacy profile documents type 2 diabetes diagnosis OR a trial of any oral antidiabetic (excluding metformin) to bypass prior authorization
    130 days
    MedicationBypass requirementLookback / threshold
    Selected antiemetics (e.g., ANZEMET, aprepitant products)
    Pharmacy profile documents a generic ondansetron fill to bypass prior authorization
    180 days
    MedicationBypass requirementLookback / threshold
    Belsomra
    Pharmacy profile documents a generic zolpidem fill to bypass prior authorization
    365 days
    MedicationBypass requirementLookback / threshold
    Binosto
    Pharmacy profile documents an alendronate fill to bypass prior authorization
    90 days
    MedicationBypass requirementLookback / threshold
    Bromfenac ophthalmic (0.07%)
    Pharmacy profile documents generic bromfenac ophthalmic solution 0.09% once-daily fill to bypass prior authorization
    90 days
    MedicationBypass requirementLookback / threshold
    Fluorouracil topical (0.5%)
    Pharmacy profile documents a fluorouracil topical fill to bypass prior authorization
    90 days
    MedicationBypass requirementLookback / threshold
    Entacapone / ONGENTYS
    Pharmacy profile documents concurrent use of a levodopa/carbidopa product to bypass prior authorization
    Concurrent use (documented)
    MedicationBypass requirementLookback / threshold
    Ongentys (entacapone) — online edit
    Independent Health prescription history documents concurrent levodopa/carbidopa use to allow online processing
    Concurrent use documented (per profile)
    MedicationBypass requirementLookback / threshold
    Diclofenac potassium (migraine) packet 50 mg
    Independent Health prescription history documents a generic NSAID (e.g., naproxen, ibuprofen, celecoxib) fill to bypass prior authorization
    180 days
    MedicationBypass requirementLookback / threshold
    Eucrisa ointment 2%
    Independent Health prescription history documents tacrolimus, pimecrolimus, or a topical corticosteroid fill to bypass prior authorization
    365 days
    MedicationBypass requirementLookback / threshold
    Fetzima formulations
    Independent Health prescription history documents a venlafaxine XR fill to bypass prior authorization
    90 days
    MedicationBypass requirementLookback / threshold
    Glycopyrrolate oral solution
    Independent Health prescription history documents a generic glycopyrrolate tablet fill to bypass prior authorization
    90 days
    MedicationBypass requirementLookback / threshold
    Gabapentin once-daily products
    Independent Health prescription history documents a gabapentin fill to bypass prior authorization
    90 days
    MedicationBypass requirementLookback / threshold
    Doxercalciferol capsules
    Independent Health prescription history documents a calcitriol fill to bypass prior authorization
    90 days

    Policy Background

    Step therapy is used to promote use of established, typically lower‑cost or first‑line medications (or required concomitant therapies) before covering alternative or higher‑cost products. Independent Health applies product‑specific step therapy rules by checking the member’s prescription history: when the required prior or concurrent fill is documented within the defined lookback window, the claim will route online without prior authorization; when that pharmacy history is not present, prior authorization is required.

    This policy ties step requirements to recent prescription fills in the Independent Health pharmacy profile and lists common lookback windows and conditions used to allow online processing (examples include 90 days, 120 days, 130 days, 180 days, and 365 days), as well as product‑specific conditions such as required concurrent therapy (for example, levodopa/carbidopa with entacapone or phosphate binder use with tenapanor). Providers and pharmacies should document the specified prior fill(s) in the member’s prescription history or submit a prior authorization when the lookback criteria are not met.

    Key Definitions

    Step therapy
    Step therapy definitionStep therapy (ST): medications with an 'ST' designation require evidence of specified prior medication fills within defined lookback windows before coverage without PA
    PurposeEncourage use of established or lower-cost medications first and ensure required co-therapy when clinically appropriate
    RoutingOnline edits allow bypass when required prior fills are documented; otherwise prior authorization is required
    narcotic-naïve
    Narcotic‑naïve definitionA patient without documented narcotic medication fills in the previous 120 days (i.e., starting high‑potency opioids in an opioid‑naïve patient is restricted)
    Policy implicationHigh‑potency narcotics require evidence of narcotic fills within prior 120 days to allow online dispensing; otherwise PA required
    Safety rationaleDesigned to prevent initiation of high‑potency opioids in narcotic‑naïve patients
    generic SSRI
    Generic SSRI examplesSertraline, fluoxetine, escitalopram (listed as examples)
    Policy useA generic SSRI fill within the previous 90 days is required to route Trintellix online without PA
    If not metPrior authorization required
    concurrent use
    Concurrent use definitionUse documented within the specified prior‑days lookback period (e.g., phosphate binder within 120 days for tenapanor; levodopa/carbidopa within 180 days for ONGENTYS)
    Policy implicationConcurrent use documented in prescription history allows online routing without PA for products requiring co‑therapy
    ExamplesLevodopa/carbidopa with ONGENTYS; phosphate binder with XPHOZAH